Some HIV drugs cause premature ageingJune 27th, 2011 - 4:21 pm ICT by IANS
London, June 27 (IANS) A class of drugs commonly prescribed for HIV in low-income countries can cause premature ageing, a study says.
The study shows these drugs damage DNA in the patient’s mitochondria - the ‘batteries’ which power our cells to carry out their functions.
The findings may explain why HIV-infected people treated with such drugs sometimes show advanced signs of frailty and risk of heart disease and dementia even at an early age.
Professor Patrick Chinnery, at the Institute of Genetic Medicine, Newcastle University, says: “HIV clinics were seeing patients who had otherwise been successfully treated but who showed signs of being much older than their years.”
“This was a real mystery. But colleagues recognised many similarities with patients affected by mitochondrial diseases - conditions that affect energy production in our cells - and referred them to our clinic,” the journal Nature Genetics quoted Chinnery as saying.
Nucleoside analogue reverse-transcriptase inhibitors (NRTIs), Zidovudine, also known as AZT, were the first class of drug developed to treat HIV, according to a Newcastle statement.
They were a major breakthrough in the treatment of the disease, greatly extending lifespan and leading the condition to be seen as a chronic (lifelong), rather than terminal, condition.
“These drugs… gave people an extra 10 or 20 years, when they would otherwise have died,” Chinnery adds.
In Europe and North America, the older NRTIs are used less commonly now due to concerns over toxicity and side-effects when taken over a long period of time.
However, as they are now off-licence and hence relatively cheap, the drugs have proved to be an important lifeline for people infected with HIV in low-income countries.
- How HIV resists AIDS preventing AZT drug - Sep 20, 2010
- Improved, '60,000 times more potent' compound to effectively treat HIV - Jan 26, 2010
- New compound 60,000 times more potent than current HIV drugs - Jan 26, 2010
- Standard re-treatment regimen for TB 'failing' in developing world - Mar 16, 2011
- First ever pill to beat HIV under FDA consideration - May 10, 2012
- Vaginal gel could offer protection against HIV - May 24, 2010
- Tracking evolution of deadly fungus which is one of world's major killers - May 04, 2011
- Not portraying drug users as dead can improve HIV treatment access - Jul 22, 2010
- Antibiotics ineffective against viral sinus infections - Mar 22, 2012
- Russia tests HIV vaccine - Feb 06, 2012
- Sepsis killing more people than AIDS: Experts (Sep 13 is World Sepsis Day) - Sep 12, 2012
- Cure for AIDS a step closer - Jul 26, 2012
- Statin may help fight HIV - Feb 17, 2011
- Drug that stops progression of Parkinson's disease in mice found - Mar 09, 2011
- DNA sections linked to osteoarthritis found - Jul 03, 2012
Tags: advanced signs, chinnery, damage dna, diseases conditions, drugs damage, energy production, frailty, genetic medicine, hiv clinics, hiv drugs, journal nature genetics, lifespan, low income countries, mitochondrial diseases, newcastle university, professor patrick, reverse transcriptase inhibitors, risk of heart disease, terminal condition, zidovudine